SCHEMBL15915420

SCHEMBL15915420

CC(NS(=O)(=O)c1ccccc1Br)C(=O)OC(C)(C)C

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.53
RECQL P46063 2/20 0.51
ALOX5AP P20292 1/20 0.49
FEN1 P39748 1/20 0.49
MAPT P10636 1/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
CA12 O43570 1/20 0.40
CA14 Q9ULX7 1/20 0.40
NPC1 O15118 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
ALDH1A1 P00352 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15915421 1.00 POLB (0.53) POLBRECQLALOX5APFEN1MAPT
SCHEMBL15917536 0.86 POLB (0.51) POLBRECQLALOX5APFEN1KMT2A
SCHEMBL789823 0.81 ADAMTS4 (0.54) POLBALOX5APFEN1CA12CA14
SCHEMBL15918110 0.81 ADAMTS4 (0.56) POLBRECQLALOX5APFEN1MAPT
SCHEMBL15923698 0.81 ADAMTS4 (0.56) POLBRECQLALOX5APFEN1MAPT
SCHEMBL15932404 0.80 POLB (0.51) POLBRECQLMAPTALDH1A1CA1
SCHEMBL8445730 0.79 MMP2 (0.59) ALOX5APFEN1CA12CA14ALDH1A1
SCHEMBL1952095 0.77 CA1 (0.50) POLBRECQLMAPTKMT2AMEN1
SCHEMBL17310031 0.75 MAPT (0.53) POLBRECQLMAPTNPSR1ALDH1A1
SCHEMBL15932405 0.75 POLB (0.53) POLBRECQLKMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495359-A1 FLAP MODULATORS Janssen Pharmaceutica NV (BE) 2019-06-12 EP disclosed
EP-3070085-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-01-09 EP disclosed
EP-2951170-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-10-24 EP disclosed
US-9884878-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2018-02-06 US disclosed
US-9745328-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-29 US disclosed
EP-3070085-A1 FLAP MODULATORS Janssen Pharmaceutica N.V. (BE) 2016-09-21 EP disclosed
US-20150376212-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-31 US disclosed
US-20150259357-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-17 US disclosed
US-9079866-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-14 US disclosed
US-20140221311-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376212-A1 FLAP MODULATORS FEN1, PGF, TBXA2R POLB 1439/4885RECQL 162/4885ALOX5AP 95/4885
US-20150259357-A1 FLAP MODULATORS PGF, FEN1, TBXA2R POLB 1233/4885RECQL 254/4885ALOX5AP 80/4885
US-20140221311-A1 FLAP MODULATORS PGF, FEN1, TBXA2R POLB 1233/4885RECQL 254/4885ALOX5AP 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.